DataCiterelevance policy v2
The efficacy and safety of medical cannabis for chronic non cancer pain: a systematic review of randomized controlled trials
DataCiterelevance policy v2
The cannabinoid system and pain
DataCiterelevance policy v2
Exclusive copyright, patent, know-how, process and technology license to use the 'Sativex' trademarks and trade names to use, import, offer, sell, have sold, commercialize, market, promote, distribute, import, export, package, label and sublicense a botanical oromucosal spray solution drug product that contains extracts of a chemically and genetically characterized cannabis plant with a ratio of the cannabinoids THC (tetrahydrocannabinol) and CBD (cannabidiol), and its formulation improvements, or backup product, to treat spasticity in multiple sclerosis and cancer pain, and to treat, prevent and diagnose all indications in humans and animals, with licensor to supply products.
DataCiterelevance policy v2
Therapeutic activation of the endocannabinoid system for opioid use disorder, chronic pain, and cancer-related pain: a review of current evidence
DataCiterelevance policy v2
<b>Efficacy of cannabinoids (isolated cannabidiol or THC:CBD 1:1) as adjuvant therapy in cancer pain: A systematic review and meta-analysis</b>
DataCiterelevance policy v2
Collaborative development with exclusive patent, know-how and process license to use the 'Sativex,' 'Nabidiolex' and 'Tetranabinex' trademarks and trade names to develop, make, have made, use, sell, import, exploit and sublicense a pharmaceutical product that is an oromucosal spray containing tetrahydrocannabinol from 'Tetrabinex' and Cannabis sativa, and cannabidiol, including formulation improvements, and other products containing a ratio of CBD and THC drug substances, to treat, diagnose, prevent and palliate advanced and early stage cancer pain, neuropathic and other pain, and other diseases, conditions, syndromes and maladies in humans and animals, including multiple sclerosis.
DataCiterelevance policy v2
Therapeutic activation of the endocannabinoid system for opioid use disorder, chronic pain, and cancer-related pain: a review of current evidence
DataCiterelevance policy v2
Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis
DataCiterelevance policy v2
<b>Efficacy of cannabinoids (isolated cannabidiol or THC:CBD 1:1) as adjuvant therapy in cancer pain: A systematic review and meta-analysis</b>
DataCiterelevance policy v2
Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis
DataCiteexact package work
Pretreating with cannabidiol (CBD) enhances chemotherapy: evidence for mitochondrial "priming"
Unpaywallexact package work
Open-access location
Unpaywallexact package work
Open-access location
Unpaywallexact package work
Open-access location
Unpaywallexact package work
Open-access location
Unpaywallexact package work
Open-access location
Unpaywallexact package work
Open-access location
Unpaywallexact package work
Open-access location
Unpaywallexact package work
Open-access location
Unpaywallexact package work
Open-access location